| Product Code: ETC8940517 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Republic of Macedonia continues to rely on imports of valganciclovir, with top exporting countries including India, Ireland, Germany, Netherlands, and China in 2024. Despite a high Herfindahl-Hirschman Index (HHI) indicating market concentration, the compound annual growth rate (CAGR) from 2020 to 2024 saw a significant decline of -15.25%. Furthermore, the growth rate from 2023 to 2024 experienced a sharp decrease of -34.5%, signaling a challenging year for valganciclovir imports in North Macedonia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Republic of Macedonia Valganciclovir Market Overview |
3.1 Republic of Macedonia Country Macro Economic Indicators |
3.2 Republic of Macedonia Valganciclovir Market Revenues & Volume, 2021 & 2031F |
3.3 Republic of Macedonia Valganciclovir Market - Industry Life Cycle |
3.4 Republic of Macedonia Valganciclovir Market - Porter's Five Forces |
3.5 Republic of Macedonia Valganciclovir Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Republic of Macedonia Valganciclovir Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Republic of Macedonia Valganciclovir Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diseases treatable by valganciclovir in Republic of Macedonia |
4.2.2 Growing awareness and adoption of advanced healthcare treatments in the region |
4.2.3 Favorable government regulations and policies supporting the pharmaceutical industry |
4.3 Market Restraints |
4.3.1 High cost associated with valganciclovir treatment may limit accessibility for some patients |
4.3.2 Limited healthcare infrastructure and resources in certain regions of Republic of Macedonia |
4.3.3 Potential side effects and risks associated with valganciclovir treatment may deter some patients |
5 Republic of Macedonia Valganciclovir Market Trends |
6 Republic of Macedonia Valganciclovir Market, By Types |
6.1 Republic of Macedonia Valganciclovir Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Republic of Macedonia Valganciclovir Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Republic of Macedonia Valganciclovir Market Revenues & Volume, By Powder, 2021- 2031F |
6.1.4 Republic of Macedonia Valganciclovir Market Revenues & Volume, By Tablet, 2021- 2031F |
6.2 Republic of Macedonia Valganciclovir Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Republic of Macedonia Valganciclovir Market Revenues & Volume, By Adults, 2021- 2031F |
6.2.3 Republic of Macedonia Valganciclovir Market Revenues & Volume, By Children, 2021- 2031F |
7 Republic of Macedonia Valganciclovir Market Import-Export Trade Statistics |
7.1 Republic of Macedonia Valganciclovir Market Export to Major Countries |
7.2 Republic of Macedonia Valganciclovir Market Imports from Major Countries |
8 Republic of Macedonia Valganciclovir Market Key Performance Indicators |
8.1 Number of healthcare facilities offering valganciclovir treatment in Republic of Macedonia |
8.2 Patient adherence rates to valganciclovir treatment regimens |
8.3 Number of clinical trials or research studies on valganciclovir efficacy and safety in Republic of Macedonia |
9 Republic of Macedonia Valganciclovir Market - Opportunity Assessment |
9.1 Republic of Macedonia Valganciclovir Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Republic of Macedonia Valganciclovir Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Republic of Macedonia Valganciclovir Market - Competitive Landscape |
10.1 Republic of Macedonia Valganciclovir Market Revenue Share, By Companies, 2024 |
10.2 Republic of Macedonia Valganciclovir Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |